Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Journal: The Biochemical journal 20130415
Title: In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines.
Journal: Veterinary and comparative oncology 20120901
Title: Receptor tyrosine kinase inhibitors: molecularly targeted drugs for veterinary cancer therapy.
Journal: Veterinary and comparative oncology 20120901
Title: Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor.
Journal: European journal of haematology 20120701
Title: NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation.
Journal: Allergy 20120701
Title: Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells.
Journal: Veterinary and comparative oncology 20120601
Title: Quantitative functional imaging by dynamic contrast enhanced ultrasonography (DCE-US) in GIST patients treated with masatinib.
Journal: Investigational new drugs 20120401
Title: Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting.
Journal: Molecular immunology 20120401
Title: Stevens-Johnson Syndrome induced by masitinib.
Journal: Acta dermato-venereologica 20120301
Title: Biological effect of tyrosine kinase inhibitors on three canine mast cell tumor cell lines with various KIT statuses.
Journal: Journal of veterinary pharmacology and therapeutics 20120201
Title: [KIT and KIT: from biology to clinical use].
Journal: Bulletin du cancer 20120201
Title: Masitinib as a chemosensitizer of canine tumor cell lines: a proof of concept study.
Journal: Veterinary journal (London, England : 1997) 20120101
Title: The tyrosine kinase inhibitor masitinib blunts airway inflammation and improves associated lung mechanics in a feline model of chronic allergic asthma.
Journal: International archives of allergy and immunology 20120101
Title: Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
Journal: BMC neurology 20120101
Title: Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial.
Journal: Veterinary dermatology 20111201
Title: Systemic therapy for advanced gastrointestinal stromal tumors: beyond imatinib.
Journal: Journal of surgical oncology 20111201
Title: Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Journal: Nature biotechnology 20111101
Title: Comprehensive analysis of kinase inhibitor selectivity.
Journal: Nature biotechnology 20111030
Title: Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors.
Journal: Seminars in oncology 20110401
Title: Stratified medicine in selecting biologics for the treatment of severe asthma.
Journal: Current opinion in allergy and clinical immunology 20110201
Title: Safety of masitinib mesylate in healthy cats.
Journal: Journal of veterinary internal medicine 20110101
Title: Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial.
Journal: Alzheimer's research & therapy 20110101
Title: Emerging therapies for severe asthma.
Journal: BMC medicine 20110101
Title: F-FDG PET Imaging in the Evaluation of Treatment Response to New Chemotherapies beyond Imatinib for Patients with Gastrointestinal Stromal Tumors.
Journal: ISRN gastroenterology 20110101
Title: Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy.
Journal: PloS one 20110101
Title: Mast cells as cellular sensors in inflammation and immunity.
Journal: Frontiers in immunology 20110101
Title: Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study.
Journal: American journal of hematology 20101201
Title: Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry.
Journal: Chemistry & biology 20101124
Title: Clinical trial on the efficacy of masitinib in canine IBD.
Journal: The Veterinary record 20101106
Title: Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors.
Journal: American journal of veterinary research 20101101
Title: Churg and Strauss vasculitis in the course of masitinib treatment: a first report.
Journal: Allergy 20100801
Title: Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer.
Journal: Cancer chemotherapy and pharmacology 20100701
Title: [Focus on GIST management].
Journal: Bulletin du cancer 20100601
Title: The complexity of the complicity of mast cells in cancer.
Journal: The international journal of biochemistry & cell biology 20100501
Title: Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).
Journal: European journal of cancer (Oxford, England : 1990) 20100501
Title: Masitinib for the treatment of canine atopic dermatitis: a pilot study.
Journal: Veterinary research communications 20100101
Title: Drug-induced minimal change nephropathy in a dog.
Journal: Journal of veterinary internal medicine 20100101
Title: Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib.
Journal: Biologics : targets & therapy 20100101
Title: c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
Journal: Arthritis research & therapy 20100101
Title: Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model.
Journal: PloS one 20100101
Title: 'Masitinib' is safe and effective for the treatment of canine mast cell tumors.
Journal: Journal of veterinary internal medicine 20100101
Title: Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11.
Journal: BMC cancer 20100101
Title: [New drugs for small animals in 2009].
Journal: Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere 20100101
Title: Pharmacokinetics of masitinib in cats.
Journal: Veterinary research communications 20091201
Title: Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers.
Journal: European journal of cancer (Oxford, England : 1990) 20090901
Title: Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics.
Journal: Allergy 20090801
Title: Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.
Journal: Arthritis research & therapy 20090101
Title: More about masitinib.
Journal: Arthritis research & therapy 20090101
Title: Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
Journal: PloS one 20090101
Title: Clinically relevant advances in rheumatoid arthritis therapy.
Journal: F1000 medicine reports 20090101
Title: [Gastrointestinal stromal tumors: molecular aspects and therapeutic implications].
Journal: Bulletin du cancer 20080101
Title: Masitinib is safe and effective for the treatment of canine mast cell tumors.
Journal: Journal of veterinary internal medicine 20080101
Title: Dubreuil P, et al. Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT. PLoS One, 2009, 4(9), e7258.
Title: Lawrence J, et al. Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells. Vet Comp Oncol, 2011, doi: 10.1111/j.1476-5829.2011.00291.x.
Title: Hahn KA, et al. Masitinib is safe and effective for the treatment of canine mast cell tumors. J Vet Intern Med, 2008, 22(6), 1301-1309.
Title: Marech I, et al. Masitinib (AB1010), from canine tumor model to human clinical development: where we are? Crit Rev Oncol Hematol. 2014 Jul;91(1):98-111.
